Advanced Theranostic Strategies for Viral Hepatitis Using Carbon Nanostructures

There are several treatment protocols for acute viral hepatitis, and it is critical to recognize acute hepatitis in its earliest stages. Public health measures to control these infections also rely on rapid and accurate diagnosis. The diagnosis of viral hepatitis remains expensive, and there is no adequate public health infrastructure, while the virus is not well-controlled. New methods for screening and detecting viral hepatitis through nanotechnology are being developed. Nanotechnology significantly reduces the cost of screening. In this review, the potential of three-dimensional-nanostructured carbon substances as promising materials due to fewer side effects, and the contribution of these particles to effective tissue transfer in the treatment and diagnosis of hepatitis due to the importance of rapid diagnosis for successful treatment, were extensively investigated. In recent years, three-dimensional carbon nanomaterials such as graphene oxide and nanotubes with special chemical, electrical, and optical properties have been used for the diagnosis and treatment of hepatitis due to their high potential. We expect that the future position of nanoparticles in the rapid diagnosis and treatment of viral hepatitis can be better determined.

Automated summary

There are various treatment protocols for acute viral hepatitis, and prompt recognition of the disease is crucial. Public health measures rely on accurate and timely diagnosis. However, existing diagnostic methods are expensive and there is a lack of adequate public health infrastructure for controlling viral hepatitis. Nanotechnology offers a potential solution by reducing screening costs and improving diagnostic accuracy. This review focuses on the use of three-dimensional carbon nanomaterials, such as graphene oxide and nanotubes, in the diagnosis and treatment of hepatitis due to their unique properties. It explores their potential contribution to effective tissue transfer and emphasizes the importance of rapid diagnosis for successful treatment. The future role of nanoparticles in the rapid diagnosis and treatment of viral hepatitis is expected to be better determined.